免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Diazyme PLAC® 测定Lp-PLA2活性

K号: K203136 · 2021-08-06

决定日期2021-08-06
产品代码NOE
咨询委员会抱歉,您提供的信息不完整,无法进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

Diazyme PLAC® Test for Lp-PLA2 Activity is the device name listed in this FDA 510(k) record. The listed applicant is Diazyme Laboratories, Inc.. It received FDA 510(k) clearance on 2021-08-06 under 510(k) number K203136. The device is classified under product code NOE. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Diazyme PLAC® Test for Lp-PLA2 Activity?

Diazyme PLAC® Test for Lp-PLA2 Activity is a medical device that received FDA 510(k) clearance on 2021-08-06. The listed applicant is Diazyme Laboratories, Inc.. The 510(k) number is K203136.

When did Diazyme PLAC® Test for Lp-PLA2 Activity receive FDA 510(k) clearance?

Diazyme PLAC® Test for Lp-PLA2 Activity received FDA 510(k) clearance on 2021-08-06, under 510(k) number K203136.

Who is the listed applicant for Diazyme PLAC® Test for Lp-PLA2 Activity?

The FDA 510(k) record lists Diazyme Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Diazyme PLAC® Test for Lp-PLA2 Activity?

The FDA product code for Diazyme PLAC® Test for Lp-PLA2 Activity is NOE.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Diazyme Laboratories, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 11 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑